Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
25.7M
-
Number of holders
-
30
-
Total 13F shares, excl. options
-
19M
-
Shares change
-
+5.07M
-
Total reported value, excl. options
-
$240M
-
Value change
-
+$64.6M
-
Number of buys
-
22
-
Number of sells
-
-7
-
Price
-
$12.63
Significant Holders of Benitec Biopharma Inc. - Common Stock (BNTC) as of Q4 2024
33 filings reported holding BNTC - Benitec Biopharma Inc. - Common Stock as of Q4 2024.
Benitec Biopharma Inc. - Common Stock (BNTC) has 30 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19M shares
of 25.7M outstanding shares and own 73.96% of the company stock.
Largest 10 shareholders include SUVRETTA CAPITAL MANAGEMENT, LLC (8.96M shares), FRANKLIN RESOURCES INC (2.94M shares), JANUS HENDERSON GROUP PLC (2.62M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.97M shares), Nantahala Capital Management, LLC (838K shares), VANGUARD GROUP INC (300K shares), Schonfeld Strategic Advisors LLC (260K shares), INFINITUM ASSET MANAGEMENT, LLC (210K shares), GEODE CAPITAL MANAGEMENT, LLC (197K shares), and BlackRock, Inc. (174K shares).
This table shows the top 30 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.